| Literature DB >> 27034572 |
Susan Seago1, Edana Stroberg1, Austin Metting1.
Abstract
We present a patient who had rheumatoid meningitis while on infliximab, a tumor necrosis factor alpha (TNF-α) inhibitor, which initially presented as transient ischemic attacks. Although our patient had been stable on infliximab for several years, her neurologic symptoms improved when her infliximab was held due to active infection and then recurred after reinitiation of therapy. Rheumatoid meningitis is exceedingly rare; however, there have been several other reports of rheumatoid meningitis developing in patients on TNF-α inhibitor therapy.Entities:
Year: 2016 PMID: 27034572 PMCID: PMC4790574 DOI: 10.1080/08998280.2016.11929419
Source DB: PubMed Journal: Proc (Bayl Univ Med Cent) ISSN: 0899-8280